ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0249

Endothelial Angiopoietin-2 Contributes to Early but Not Late Kidney Injury After Unilateral Ureteral Obstruction

Session Information

Category: CKD (Non-Dialysis)

  • 2203 CKD (Non-Dialysis): Mechanisms

Authors

  • Luo, An Jie, National Taiwan University College of Medicine, Taipei City, Taiwan
  • Chang, Fan-Chi, National Taiwan University Hospital, Taipei City, Taiwan
  • Lin, Shuei-Liong, National Taiwan University College of Medicine, Taipei City, Taiwan
Background

Chronic kidney disease (CKD) is characterized by persistent inflammation and fibrosis. Angiopoietin-2 has been associated with endothelial dysfunction and vascular inflammation; however, its endothelial-specific role in CKD remains unclear. This study investigated the effects of endothelial-derived angiopoietin-2 in unilateral ureteral obstruction (UUO)-induced CKD.

Methods

Endothelial cell-specific angiopoietin-2 knockout mice (Angpt2ΔEC) and control mice underwent UUO or sham surgery. Mice were sacrificed on day 4 or day 14 after surgery to evaluate early- and late-stage CKD, respectively. Kidney tissues were harvested for quantitative PCR (qPCR), protein analysis, endothelial cell isolation, and immunofluorescence staining for F4/80+ macrophages.

Results

In early UUO-induced CKD, Angpt1 expression showed no significant difference between groups. In contrast, Angpt2 expression was significantly increased after UUO in control mice, whereas Angpt2ΔEC mice exhibited significantly lower renal Angpt2 mRNA and protein levels, indicating effective endothelial-specific deletion. Expression of the pro-inflammatory genes Ccl2 and Cx3cl1, as well as the adhesion molecules Icam1 and Vcam1, was significantly reduced in Angpt2ΔEC kidneys compared with controls on day 4 after UUO. Immunofluorescence staining also demonstrated decreased F4/80+ macrophage infiltration in Angpt2ΔEC mice. Furthermore, isolated renal endothelial cells from Angpt2ΔEC mice showed significantly reduced Cx3cl1 and Icam1 expression, suggesting that endothelial-derived angiopoietin-2 promotes inflammatory activation during early CKD.
At day 14 after UUO, pro-inflammatory, adhesion molecule, and pro-fibrotic genes were markedly elevated in both groups; however, no significant differences were observed between Angpt2ΔEC and control mice.

Conclusion

These findings demonstrate that endothelial-derived angiopoietin-2 plays an important role in early CKD-associated inflammation. Endothelial-specific deletion of angiopoietin-2 attenuated inflammatory gene expression and macrophage infiltration during early UUO injury, but this protective effect was diminished in late-stage CKD. These results suggest that angiopoietin-2 contributes to CKD progression in a stage-dependent manner and may serve as a therapeutic target in early CKD.